(S1 (S (NP (NP (NN Identification)) (PP (IN of) (NP (DT a) (JJ novel) (JJ human) (NN uridine) (NN phosphorylase))) (. .))))
(S1 (S (NP (NN Uridine) (NN phosphorylase)) (VP (VBZ catalyzes) (NP (NP (DT the) (JJ reversible) (JJ phosphorylytic) (NN cleavage)) (PP (IN of) (NP (NP (NN uridine)) (CC and) (NP (NN deoxyuridine)))) (PP (TO to) (NP (NP (NN uracil)) (CC and) (NP (NP (NN ribose-)) (CC or) (NP (NN deoxyribose-1-phosphate))))))) (. .)))
(S1 (S (S (NP (DT The) (NN enzyme)) (VP (VBZ has) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN pyrimidine) (NNS analogs)) (VP (VBN used) (PP (IN in) (NP (NN cancer) (NN chemotherapy)))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN cDNA)) (PP (IN of) (NP (NP (DT a) (JJ novel) (CD 317) (NN amino) (NN acid) (JJ human) (NN uridine) (NN phosphorylase)) (ADJP (NP (QP (RB approximately) (CD 60)) (NN %)) (JJ identical) (PP (TO to) (NP (DT the) (ADJP (RB previously) (VBN identified)) (JJ human) (NN uridine) (NN phosphorylase))))))) (VP (VBD was) (VP (VBN cloned)))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ novel) (NN enzyme)) (, ,) (VP (VBN named) (S (NP (NP (NN uridine) (NN phosphorylase-2)) (PRN (-LRB- -LRB-) (NP (NN UPase-2)) (-RRB- -RRB-))))) (, ,)) (VP (VBD showed) (NP (NP (JJ broad) (JJ substrate) (NN specificity)) (CC and) (NP (VBN accepted) (NP (NP (NN uridine)) (, ,) (NP (NN deoxyuridine)) (, ,) (CC and) (NP (NN thymidine)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (CD two) (NN pyrimidine) (NN nucleoside) (NNS analogs)) (NP (NP (NN 5-fluorouridine)) (CC and) (NP (NN 5-fluoro-2-LRB-'-RRB--deoxyuridine))))))) (. .)))
(S1 (S (S (S (NP (DT The) (JJ human) (NN UPase-2) (NN gene)) (VP (VBD was) (VP (VBN mapped) (PP (TO to) (NP (NN chromosome) (CD 2q24.1)))))) (CC and) (S (NP (DT the) (JJ 2.2-kb) (NN mRNA)) (VP (VBD was) (ADVP (RB predominantly)) (VP (VBN expressed) (PP (IN in) (NP (NN kidney))))))) (. .)))
(S1 (S (S (NP (DT The) (NN mouse) (NN UPase-2) (NN cDNA)) (VP (VBD was) (ADVP (RB also)) (VP (VP (VBN identified)) (CC and) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADVP (RB predominantly)) (VP (VBN expressed) (PP (IN in) (NP (NN liver))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN identification)) (PP (IN of) (NP (NP (DT a) (JJ novel) (NN uridine) (NN phosphorylase)) (PP (IN with) (NP (JJ broad) (JJ substrate) (NN specificity)))))) (VP (VBZ is) (ADJP (JJ important) (PP (PP (IN for) (NP (NP (NNS studies)) (PP (IN on) (NP (DT both) (NN nucleoside) (NN metabolism))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN for) (NP (NP (NNS studies)) (PP (IN on) (NP (NP (DT the) (JJ pharmacological) (NNS mechanisms)) (PP (IN of) (NP (JJ therapeutic) (NN pyrimidine) (NN nucleoside) (NNS analogs))))))))))) (. .)))
